A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects
Clinical trial NCT07334496 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07334496
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2026-07-17
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.